.
GTHX financial statements
* Numbers in thousands
Year |
2017 | 2018 | 2019 | 2020 | 2021 | TTM |
|---|---|---|---|---|---|---|
Capitalization * |
465 504 | 701 983 | 787 109 | 913 997 | 399 253 | 392 048 |
EV * |
361 692 | 332 693 | 518 583 | 734 449 | 184 817 | 184 817 |
Stock price $ |
25.58 | 21.07 | 20.99 | 24.13 | 9.42 | 9.25 |
Number of shares * |
18 198 | 33 317 | 37 499 | 37 878 | 42 384 | 42 384 |
EPS |
-3,30 | -2,56 | -3,27 | -2,62 | -3,50 | -3,50 |
Revenue * |
0 | 0 | 0 | 45 285 | 31 476 | 31 476 |
Net income * |
-60 121 | -85 288 | -122 447 | -99 254 | -148 352 | -148 352 |
Operating profit * |
-60 968 | -89 286 | -129 041 | -96 476 | -142 457 | -142 457 |
Total liabilities * |
11 783 | 12 450 | 29 304 | 51 201 | 110 553 | 110 553 |
Net debt * |
-103 812 | -369 290 | -258 991 | -179 548 | -221 186 | -221 186 |
Total assets * |
105 171 | 371 270 | 284 831 | 228 552 | 254 094 | 254 094 |
Equity * |
93 388 | 358 820 | 255 527 | 177 351 | 143 541 | 143 541 |
Cash and investments * |
103 812 | 369 290 | 269 208 | 207 306 | 221 186 | 221 186 |
Over the past 10 years, the maximum capitalization of G1 Therapeutics, Inc. is 913 997, the minimum is 399 253. Maximum net income 0, Minimum net income -148 352. The maximum price of GTHX shares is 25.58, the minimum price is 9.42.
.
GTHX valuation
Year |
2017 | 2018 | 2019 | 2020 | 2021 | TTM |
|---|---|---|---|---|---|---|
P/E |
-7,74 | -8,23 | -6,43 | -9,21 | -2,69 | -2,64 |
P/B |
4,98 | 1,96 | 3,08 | 5,15 | 2,78 | 2,73 |
P/S |
0,00 | 0,00 | 0,00 | 20,18 | 12,68 | 12,46 |
E/P |
-13% | -12% | -16% | -11% | -37% | -38% |
P/FCF |
-9,16 | -9,36 | -7,70 | -10,91 | -3,02 | -2,97 |
.
GTHX profitability
Year |
2017 | 2018 | 2019 | 2020 | 2021 | TTM |
|---|---|---|---|---|---|---|
ROE |
-64% | -24% | -48% | -56% | -103% | |
ROA |
-57% | -23% | -43% | -43% | -58% | |
ROIC |
-65% | -25% | -49% | -47% | -63% |